Crossmark

Ciprofloxacin DPI: a randomised, placebo-controlled, phase IIb efficacy and safety study on cystic fibrosis

Crossref DOI link: https://doi.org/10.1136/bmjresp-2015-000100

Published Online: 2015-12-07

Published Print: 2015-12

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Dorkin, Henry L

Staab, Doris

Operschall, Elisabeth

Alder, Jeff

Criollo, Margarita
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct00645788 at ClinicalTrials.gov

Documents that mention this clinical trial

Ciprofloxacin DPI: a randomised, placebo-controlled, phase IIb efficacy and safety study on cystic fibrosis
https://doi.org/10.1136/bmjresp-2015-000100

nct00645788 at ClinicalTrials.gov

Documents that mention this clinical trial

Ciprofloxacin DPI: a randomised, placebo-controlled, phase IIb efficacy and safety study on cystic fibrosis
https://doi.org/10.1136/bmjresp-2015-000100